Tumor suppressor p53 is required to modulate BRCA1 expression

Molecular and Cellular Biology

Volumn 20, Issue 20, 2000, Pages 7450-7459

  Arizti, P ^a   Fang, L ^a   Park, I ^a   Yin, Y ^a   Solomon, E ^a   Ouchi, T ^a   Aaronson, S A ^a   Lee, S W ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GENE MUTATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ANIMAL; BRCA1 PROTEIN; CELL CYCLE; CELLS, CULTURED; DNA DAMAGE; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMAN; MICE; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN P53; REPRESSOR PROTEINS; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION;

EID: 0033805548     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.20.7450-7459.2000     Document Type: Article

References (67)

1. The p53 network
2. Identification of newly transcribed RNA
3. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types
4. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer
5. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter
6. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
7. 1 arrest and apoptosis functions of the p53 tumor suppressor protein
8. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway
9. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks
10. Growth retardation. DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice
11. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
12. Wild-type p53 can down-modulate the activity of various promoters
13. The p53 tumor suppressor inhibits transcription of the TATA-less mouse DP1 promoter
14. p53 facilitates pRb cleavage in IL-3-deprived cells: Novel pro-apoptotic activity of p53
15. BRCA1 required for transcription-coupled repair of oxidative DNA damage
16. Synergistic activation of transcription by CBP and p53
17. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
18. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation
19. p53; from inductive signal to cellular effect
20. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
21. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL
22. Database of p53 gene somatic mutations in human tumors and ceil lines
23. Allosteric activation of latent p53 tetramers
24. Regulation of the specific DNA binding function of p53
25. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis
26. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains
27. p53: Puzzle and paradigm
28. p53, the cellular gatekeeper for growth and division
29. Binding and modulation of p53 by p300/CBP coactivators
30. Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
31. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
32. Evidence for a transcriptional activation function of BRCA1 C-terminal region
33. Negative feedback regulation of wild-type p53 biosynthesis
34. Brca1 controls homology-directed DNA repair
35. Wild-type p53 negatively regulates the expression of a microtubule-associated protein
36. BRCA1 regulates p53-dependent gene expression
37. Genetic determinants of p53-induced apoptosis and growth arrest
38. The genetics of breast cancer susceptibility
39. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours
40. Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells
41. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression
42. BRCA1 is a cell cycle-regulated nuclear phosphoprotein
43. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site
44. Genetic analysis of BRCA1 function in a defined tumor cell line
45. Association of BRCA1 with Rad51 in mitotic and meiotic cells
46. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
47. BRCA1 is a component of the RNA polymerase II holoenzyme
48. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
49. Negative regulation of Rb expression by the p53 gene product
50. DNA damage induces phosphorylation of the amino terminus of p53
51. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
52. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction
53. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
54. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases
55. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage
56. Repression of p53-mediated transcription by MDM2: A dual mechanism
57. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor
58. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases
59. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage
60. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
61. The p53-mdm-2 autoregulatoty feedback loop
62. Complex regulation of the BRCA1 gene
63. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
64. BRCA1, BRCA2, and DNA damage response: Collision or collusion?
65. BRCA1 physically associates with p53 and stimulates its transcriptional activity
66. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response